Literature DB >> 11850858

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Walter T Hughes1, Donald Armstrong, Gerald P Bodey, Eric J Bow, Arthur E Brown, Thierry Calandra, Ronald Feld, Philip A Pizzo, Kenneth V I Rolston, Jerry L Shenep, Lowell S Young.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11850858     DOI: 10.1086/339215

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  360 in total

1.  Risk factors for renal failure in pediatric patients with acute myeloid leukemia: a retrospective cohort study.

Authors:  Brian T Fisher; Theoklis E Zaoutis; Kateri H Leckerman; Russell Localio; Richard Aplenc
Journal:  Pediatr Blood Cancer       Date:  2010-10       Impact factor: 3.167

Review 2.  Specific infectious complications after stem cell transplantation.

Authors:  Holger Hebart; Hermann Einsele
Journal:  Support Care Cancer       Date:  2003-08-15       Impact factor: 3.603

3.  Withholding initial vancomycin in febrile neutropenia despite implanted catheters.

Authors:  Christoph Berger; Karin Kindli; Felix K Niggli; David Nadal
Journal:  Eur J Pediatr       Date:  2004-05-13       Impact factor: 3.183

Review 4.  Assessing ethics of trials in systematic reviews.

Authors:  Michael A Weingarten; Mical Paul; Leonard Leibovici
Journal:  BMJ       Date:  2004-04-24

5.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

6.  Bacterial substitution of coagulase-negative staphylococci for streptococci on the oral mucosa after hematopoietic cell transplantation.

Authors:  Yoshihiko Soga; Yoshinobu Maeda; Fumihiko Ishimaru; Mitsune Tanimoto; Hiroshi Maeda; Fusanori Nishimura; Shogo Takashiba
Journal:  Support Care Cancer       Date:  2010-06-10       Impact factor: 3.603

7.  Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies.

Authors:  Enrico Maria Trecarichi; Mario Tumbarello; Morena Caira; Anna Candoni; Chiara Cattaneo; Domenico Pastore; Rosa Fanci; Annamaria Nosari; Nicola Vianelli; Alessandro Busca; Antonio Spadea; Livio Pagano
Journal:  Haematologica       Date:  2011-01       Impact factor: 9.941

8.  Prophylaxis of invasive fungal diseases in patients with hematologic disorders.

Authors:  Corrado Girmenia
Journal:  Haematologica       Date:  2010-10       Impact factor: 9.941

9.  Fungal pathogens and primary antifungal prophylaxis in patients with hematological malignancies: one year experience.

Authors:  H Gedik; M T Yildirmak; F Simsek; D Aydin; N Demirel; O Yokus; D Arica
Journal:  Afr Health Sci       Date:  2012-09       Impact factor: 0.927

Review 10.  [Therapy of severe fungal infections].

Authors:  M Battegay; U Flückiger
Journal:  Internist (Berl)       Date:  2003-12       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.